Combining Radiotherapy with SOC Plus Abiraterone Improves rPFS in Patients with Low-Volume de Novo Metastatic Castration-Sensitive Prostate Cancer By Ogkologos - December 5, 2024 458 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PEACE-1 study Source RELATED ARTICLESMORE FROM AUTHOR Sacituzumab Govitecan Plus Pembrolizumab Prolongs PFS Among Patients with Previously Untreated, PD-L1-positive, Advanced TNBC FDA Grants Regular Approval to Rucaparib for Metastatic Castration-Resistant Prostate Cancer FDA Approves Lisocabtagene Maraleucel for Relapsed or Refractory Marginal Zone Lymphoma MOST POPULAR Significant Interaction Between a Chemotherapy Benefit and Menopausal Status Found in... December 7, 2021 How to Tell If Cancer Information on Social Media Is “Fake... September 29, 2020 ESMO Breast Cancer 2025, Munich, Germany, 14-17 May 2025 May 7, 2025 Utility of Serial ctDNA in Guiding Anti-EGFR Rechallenge in Metastatic Colorectal... September 7, 2022 Load more HOT NEWS EMA Recommends Granting a Marketing Authorisation for Asciminib FDA Grants Accelerated Approval to Tafasitamab-cxix for DLBCL EMA Recommends Granting a Conditional Marketing Authorisation for Pralsetinib Is there a right way to check your body for cancer?
